Christine Archbold compensation by year
AdaptHealth Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $378,567 |
| Bonus | $0 |
| Stock awards | $753,008 |
| Option awards | $0 |
| Non-equity incentive | $214,732 |
| Pension and deferred compensation | $0 |
| All other | $9,442 |
| Total | $1,355,749 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AdaptHealth Corp. DEF 14A filed April 30, 2025, accession 0001628280-25-020890, and prior-year filings. Open the filing on EDGAR.
How this page was built: the AdaptHealth Corp. filed document, accession 0001628280-25-020890. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 28,536 | $271,663 | — |
| PSU | 17,121 | $162,992 | — |
| PSU | 11,415 | $108,671 | — |
| PSU | 8,393 | $79,901 | — |
| RSU | 5,596 | $53,274 | — |
| RSU | 2,036 | $19,383 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in AdaptHealth Corp.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2024 proxy (filed April 30, 2025)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-01-30 | Grant or award | — | 32,213 | $0.00 | 107,198 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments AdaptHealth discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $0 | $695,883 | $0 | $695,883 |
Per the Potential Payments Upon Termination or Change in Control table in AdaptHealth Corp.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
AdaptHealth’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Joshua Parnes | Former President | $10,441,920 |
| Suzanne Foster | Chief Executive Officer | $8,391,752 |
| Jason Clemens | Chief Financial Officer | $6,352,226 |
| Albert Prast | Chief Technology Officer | $2,852,105 |
| Shaw Rietkerk | Former Chief Operating Officer | $2,384,126 |
| Richard Barasch | Former Interim Chief Executive Officer | $2,074,106 |
| Christine Archbold · this page | Chief Accounting Officer | $1,355,749 |
| Toby Barnhart | Chief Operating Officer | $1,347,142 |
The full AdaptHealth compensation record
free company briefThis page is one person within AdaptHealth's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the AdaptHealth proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AdaptHealth's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.